SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-006586
Filing Date
2023-03-08
Accepted
2023-03-08 07:15:35
Documents
14
Period of Report
2023-03-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcrx-20230308.htm   iXBRL 8-K 58406
2 EX-99.1 tcrx-ex99_1.htm EX-99 220068
3 GRAPHIC img207367504_0.jpg GRAPHIC 29064
  Complete submission text file 0000950170-23-006586.txt   457343

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrx-20230308.xsd EX-101.SCH 2465
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrx-20230308_lab.xml EX-101.LAB 17919
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrx-20230308_pre.xml EX-101.PRE 11109
8 EXTRACTED XBRL INSTANCE DOCUMENT tcrx-20230308_htm.xml XML 4707
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40603 | Film No.: 23714862
SIC: 2836 Biological Products, (No Diagnostic Substances)